Jimin Yuan

1.1k total citations · 1 hit paper
20 papers, 782 citations indexed

About

Jimin Yuan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jimin Yuan has authored 20 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Jimin Yuan's work include Melanoma and MAPK Pathways (6 papers), interferon and immune responses (4 papers) and Cancer-related Molecular Pathways (3 papers). Jimin Yuan is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), interferon and immune responses (4 papers) and Cancer-related Molecular Pathways (3 papers). Jimin Yuan collaborates with scholars based in China, Singapore and United States. Jimin Yuan's co-authors include Jiajun Yap, Jiancheng Hu, Xiaoduo Dong, Chuanbin Yang, Lingyun Dai, Jigang Wang, Zhijie Li, Junyun Huang, Tianyu Zhong and Jianing Zhong and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Jimin Yuan

19 papers receiving 775 citations

Hit Papers

The MAPK and AMPK signali... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jimin Yuan China 11 532 208 124 99 84 20 782
Dong‐Hoon Jin South Korea 16 494 0.9× 168 0.8× 127 1.0× 72 0.7× 77 0.9× 39 745
Ke Huang China 17 504 0.9× 236 1.1× 141 1.1× 58 0.6× 81 1.0× 68 841
Rareş Drulă Romania 11 601 1.1× 292 1.4× 189 1.5× 84 0.8× 67 0.8× 18 914
Ángeles Carlos‐Reyes Mexico 13 549 1.0× 254 1.2× 200 1.6× 51 0.5× 95 1.1× 31 908
Sreedevi Avasarala United States 14 632 1.2× 185 0.9× 176 1.4× 45 0.5× 78 0.9× 19 967
Xuan Zhou China 17 595 1.1× 184 0.9× 206 1.7× 71 0.7× 103 1.2× 49 1.0k
Xiangxuan Zhao China 19 780 1.5× 386 1.9× 189 1.5× 142 1.4× 121 1.4× 39 1.2k
Nagathihalli S. Nagaraj United States 17 528 1.0× 243 1.2× 306 2.5× 65 0.7× 80 1.0× 26 972
Maryam Rezaei Iran 19 450 0.8× 261 1.3× 137 1.1× 45 0.5× 96 1.1× 52 840

Countries citing papers authored by Jimin Yuan

Since Specialization
Citations

This map shows the geographic impact of Jimin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jimin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jimin Yuan more than expected).

Fields of papers citing papers by Jimin Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jimin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jimin Yuan. The network helps show where Jimin Yuan may publish in the future.

Co-authorship network of co-authors of Jimin Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Jimin Yuan. A scholar is included among the top collaborators of Jimin Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jimin Yuan. Jimin Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yap, Jiajun, Junjun Chen, Nico Boon, et al.. (2025). Oncogenic non-V600 mutations evade the regulatory machinery of RAF including the Cdc37/Hsp90 chaperone and the 14-3-3 scaffold. Theranostics. 15(5). 2035–2051.
2.
Yap, Jiajun, et al.. (2023). BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes. Molecular Cancer. 22(1). 125–125. 7 indexed citations
3.
Yap, Jiajun, et al.. (2023). Abstract 19: Braf(v600e) mutation together with loss of trp53 or pten drives the origination of hairy cell leukemia from b-lymphocyte. Cancer Research. 83(7_Supplement). 19–19. 2 indexed citations
4.
Chen, Fan, Lingling Shu, Xinming Yang, et al.. (2022). Pivotal role of cytosolic phospholipase PLA2G4A in the pathogenesis of FLT3-ITD-mutated acute myeloid leukemia. Genes & Diseases. 10(1). 22–25. 2 indexed citations
5.
Zhang, Jingjing, Jimin Yuan, Zhijie Li, et al.. (2021). Exploring and exploiting plant cyclic peptides for drug discovery and development. Medicinal Research Reviews. 41(6). 3096–3117. 13 indexed citations
6.
Yang, Chuanbin, Wei Zhang, Xiaoduo Dong, et al.. (2020). A natural product solution to aging and aging-associated diseases. Pharmacology & Therapeutics. 216. 107673–107673. 30 indexed citations
7.
Liu, Dongcheng, Wei Li, Jianhua Yin, et al.. (2020). METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer. Frontiers in Pharmacology. 11. 178–178. 41 indexed citations
8.
Xiao, Yongwei, Jianing Zhong, Junyun Huang, et al.. (2020). Exosomes as potential sources of biomarkers in colorectal cancer. Cancer Letters. 476. 13–22. 144 indexed citations
9.
Yuan, Jimin, Xiaoduo Dong, Jiajun Yap, & Jiancheng Hu. (2020). The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. Journal of Hematology & Oncology. 13(1). 113–113. 346 indexed citations breakdown →
10.
Yap, Jiajun, et al.. (2019). Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods. Journal of Visualized Experiments. 4 indexed citations
11.
Munusamy, Prabhakaran, Jimin Yuan, Timothy Wai Ho Shuen, et al.. (2019). Assessment of PARP4 as a candidate breast cancer susceptibility gene. Breast Cancer Research and Treatment. 177(1). 145–153. 10 indexed citations
12.
Yuan, Jimin, Paula Yeng Po Lam, Yu Wang, et al.. (2018). The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants. Oncogene. 37(43). 5719–5734. 33 indexed citations
13.
Yuan, Jimin, et al.. (2018). Activating mutations in MEK1 enhance homodimerization and promote tumorigenesis. Science Signaling. 11(554). 39 indexed citations
14.
Yuan, Jimin, et al.. (2018). The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho–Ser-621 in the C terminus of CRAF. Journal of Biological Chemistry. 293(37). 14276–14284. 14 indexed citations
15.
16.
Yuan, Jimin, et al.. (2015). Functional characterization of viral tumor necrosis factor receptors encoded by cyprinid herpesvirus 3 (CyHV3) genome. Fish & Shellfish Immunology. 45(2). 757–770. 17 indexed citations
17.
Yuan, Jimin, Bai‐Liang He, Chang-Jun Guo, et al.. (2014). Interaction of Infectious Spleen and Kidney Necrosis Virus ORF119L with PINCH Leads to Dominant-Negative Inhibition of Integrin-Linked Kinase and Cardiovascular Defects in Zebrafish. Journal of Virology. 89(1). 763–775. 8 indexed citations
19.
Fang, Jing‐Yuan, et al.. (1997). Relationship of plasma folic acid and status of DNA methylation in human gastric cancer. Journal of Gastroenterology. 32(2). 171–175. 31 indexed citations
20.
Fishman, Mark C., et al.. (1996). Prevention of apoptosis in CNTF-dependent neurons by a mutant ICE and by viral protein CrmA but not by proto-oncogene product Bcl-2.. PubMed. 3(1). 105–12. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026